BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 29050758)

  • 1. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
    Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
    Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary responses to pathogen-specific antigens in latent Mycobacterium tuberculosis infection.
    Jarvela JR; Tuscano L; Lee H; Silver RF
    Tuberculosis (Edinb); 2016 Jan; 96():158-64. PubMed ID: 26732045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong purified protein derivative responses are associated with poor mycobacterium inhibition in latent TB.
    Kang JS; Cherian A; Gan SH; Lee TH; Lee KC; Chee CB; Doherty TM; Wang YT; Seah GT
    Eur Respir J; 2010 Aug; 36(2):348-54. PubMed ID: 19996195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4
    Borgström EW; Fröberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Ängeby K; Tecleab T; Ruhwald M; Andersen P; Källenius G; Bruchfeld J
    Tuberculosis (Edinb); 2020 Jul; 123():101959. PubMed ID: 32741535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers.
    Agarwal S; Nguyen DT; Lew JD; Teeter LD; Yamal JM; Restrepo BI; Brown EL; Dorman SE; Graviss EA
    Tuberculosis (Edinb); 2016 Dec; 101S():S83-S91. PubMed ID: 27727133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell response to alpha crystallin and Mycobacterium tuberculosis specific antigens using ex-vivo elispot assay for detecting latent tuberculosis infection in Addis Ababa, Ethiopia.
    Mamo G; Mihret A; Taffesse M; Gebru G; Afework M; Yamuah LK; Wassie L; Abebe M; Aseffa A; Parida SK
    Ethiop Med J; 2014 Jan; Suppl 1():15-22. PubMed ID: 24696984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.
    Day CL; Moshi ND; Abrahams DA; van Rooyen M; O'rie T; de Kock M; Hanekom WA
    PLoS One; 2014; 9(4):e94949. PubMed ID: 24740417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of latent tuberculosis infection in a low endemic country.
    de Paus RA; van Meijgaarden KE; Prins C; Kamphorst MH; Arend SM; Ottenhoff THM; Joosten SA
    Tuberculosis (Edinb); 2017 Sep; 106():62-72. PubMed ID: 28802407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA response to ESAT-6/CFP-10 and Rv2031 antigens varies in patients with culture-confirmed pulmonary tuberculosis, healthy Mycobacterium tuberculosis-infected and non-infected individuals in a tuberculosis endemic setting, Ethiopia.
    Legesse M; Ameni G; Medhin G; Mamo G; Franken KL; Ottenhoff TH; Bjune G; Abebe F
    Scand J Immunol; 2013 Sep; 78(3):266-74. PubMed ID: 23713613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.